Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation
Caterina Gregorio(University of Trieste), Francesca Ieva(Humanitas University), Saverio D’Amico(Humanitas University), Pierre Fenaux(Hôpital Avicenne), Torsten Haferlach(Munich Leukemia Laboratory (Germany)), Cristina Astrid Tentori(IRCCS Humanitas Research Hospital), María Díez‐Campelo(Complejo Hospitalario de Salamanca), Uwe Platzbecker(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Marta Spreafico(Leiden University), Luca Lanino(Humanitas University), Matteo Giovanni Della Porta(Humanitas University), Elisabetta Sauta(Humanitas University), Gianluca Asti(IRCCS Humanitas Research Hospital), Rami S. Komrokji(Moffitt Cancer Center)
Cited by 4
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Clinical and biological implications of driver mutations in myelodysplastic syndromes
|Blood|2013|1.8k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k